History
  • No items yet
midpage
Dow Chemical Co. v. Nova Chemicals Corp. (Canada)
458 F. App'x 910
Fed. Cir.
2012
Read the full case

Background

  • Dow sued Nova for infringement of U.S. patents 5,847,053 and 6,111,023; Nova challenged standing, indefiniteness, and infringement; district court held Dow had standing, patents not indefinite, jury found infringement and awarded damages; Nova appealed; this court affirmed standing and validity and infringement findings; core issue is whether Dow transferred Patent Rights to Dow Global Technologies, Inc. (DGTI) under Dow’s Contribution Agreement; Schedule A lists patents transferred, Schedule D lists excluded patents; extrinsic evidence debated but contract terms controlled; district court found no transfer of the patents-in-suit to DGTI and Dow had standing; the panel affirmed.
  • Dow and DGTI engaged in a tax-driven scheme where DGTI owned Patent Rights and licensed back to Dow; Section 2.01 purports transfer of all Patent Rights to DGTI; Section 1.07 defines Patent Rights and exclusions, including “loss of rights”; Schedule A was intended to list transferred patents but its exact contents were contentious; contemporaneous communications showed concern about standing in pending litigation and led to the “loss of rights” clause; evidence showed the patents-in-suit were not listed in Schedule A at the relevant time, supporting Dow’s lack of standing absent later actions such as a quitclaim.
  • The district court treated Schedule A as controlling for transfer; the majority affirms standing and thus sustains the infringement verdict; the dissent argues the 2002 agreement did transfer the patents-in-suit to DGTI and Dow lacked standing at filing.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Standing to sue established Dow Nova Dow had standing; patents not transferred to DGTI under the Agreement.
Indefiniteness of SHC-based claims Dow Nova Claims not indefinite; SHC defined and measurable by ordinary skilled person.
Infringement supported by substantial evidence Dow Nova Yes, jury verdict supported by substantial evidence.

Key Cases Cited

  • SiRF Tech., Inc. v. Int’l Trade Comm’n, 601 F.3d 1319 (Fed.Cir.2010) (presumption of validity from PTO assignment recording; burden to rebut)
  • Arachnid, Inc. v. Merit Indus., Inc., 939 F.2d 1574 (Fed.Cir.1991) (standing and assignment considerations in patent transfers)
  • Exxon Research & Eng’g Co. v. United States, 265 F.3d 1371 (Fed.Cir.2001) (indefiniteness requires discernible meaning; some experimentation not fatal)
  • Enzo Biochem, Inc. v. Applera Corp., 599 F.3d 1325 (Fed.Cir.2010) (claims not indefinite if enablement; some experimentation allowed)
  • DCV Holdings, Inc. v. ConAgra, Inc., 889 A.2d 954 (Del.2005) (specific vs. general language; contract interpretation)
Read the full case

Case Details

Case Name: Dow Chemical Co. v. Nova Chemicals Corp. (Canada)
Court Name: Court of Appeals for the Federal Circuit
Date Published: Jan 24, 2012
Citation: 458 F. App'x 910
Docket Number: 2010-1526
Court Abbreviation: Fed. Cir.